The PKC activator bryostatin-1 and its analogs increase the survival of dermal fibroblast cells. Bryostatin and picolog, a synthetic analog, are used as candidate therapeutic agents for improving the appearance of aging skin, reducing scar tissue formation, and improving the acceptance of a clinical skin grafts.